The difference between open-ended questions and closed-ended questions and their uses
In this practicum needs assessment, both open-ended and closed-ended questions are formulated to gather qualitative and quantitative data respectively. Open-ended questions will be used for gathering data from various sources to gain insight into reducing the side effects of high doses of cytarabine. Conversely, closed-ended questions will be used for collecting quantifiable data for the statistical significance of the study. Overall, these questions are designed to assess different data sources and points to collect relevant information for a needs assessment to reduce the side effects of high doses of cytarabine (Szoch & Kaiser, 2015).
Association with a Needs Assessment
The following open-ended and closed-ended questions are designed to explore various data sources and points to gather relevant information for a needs assessment to reduce the side effects of high doses of cytarabine. They include important themes for the nurse, physicians, and pharmacist involvement; resources; standard guides; and perceived solutions among others (American Nurses Credentialing Center, 2014).
Questions
Open-ended Questions
- What is the facility’s commitment to reduce the side effects of high doses of cytarabine observed in some patients who undergo chemotherapy treatment?
- Is the healthcare facility having adequate senior executive support to reduce the side effects of high doses of cytarabine observed in some patients who undergo chemotherapy treatment?
- What effective collaborative procedures among nurses, pharmacists, physicians, and patients have been established in this hospital to reduce the side effects of high doses of cytarabine?
- Has the hospital implemented any standardized procedures for cytarabine administration?
- Has the hospital previously conducted any studies to determine the cause and risk factors for high doses of cytarabine?
- Explain how the hospital has used any evidence-based outcomes to assess progress, identify issues, and achievements to reduce side effects of high doses of cytarabine
- Explain how nurse protocol work to handle patients noted with side effects of high doses of cytarabine
- What are typical challenges experienced in attempts to combat high doses of cytarabine?
- What specific factors are linked with the side effects of high doses of cytarabine?
- What solutions do you offer for the hospital to improve on the administration of cytarabine to chemotherapy patients to avoid adverse effects of high doses?
Close-ended Questions
- Is the hospital administering the right doses of cytarabine to chemotherapy patients of treatment?
- Is there a written commitment by the facility to reduce the side effects of high doses of cytarabine observed in some patients who undergo chemotherapy treatment?
- Has the hospital created a multidisciplinary team that includes all relevant stakeholders such as nurses, pharmacists, and physicians to handle the administration of cytarabine and possible adverse side effects?
- Do all interventional nurses and physicians have the required competencies to handle noted cases of side effects of high doses of cytarabine?
- Indicate whether the facility has a robust data collection for side effects of high doses of cytarabine
- Are there obstacles to improving the administration of high doses of cytarabine?
- Has the hospital developed any procedures to mitigate negative outcomes on patients and nursing practices based on high doses of cytarabine?
- Do care providers adhere to standardized guides for chemotherapy patients who receive doses of cytarabine?
- What is the primary guide used as the standard intervention for side effects of high doses of cytarabine among patients in this hospital?
- Is organizational culture supportive of improving side effects of high doses of cytarabine observed in some patients who undergo chemotherapy treatment?
References
American Nurses Credentialing Center. (2014). The Importance of Evaluating the Impact of Continuing Nursing Education on Outcomes: Professional Nursing Practice and Patient Care. Web.
Szoch, S., & Kaiser, K. S. (2015). Implementation and Evaluation of a High-Dose Cytarabine Neurologic Assessment Tool. Clinical Journal of Oncology Nursing, 19(3), 270-2. Web.